Flaxseed oil shows promise for blood sugar control
NCT ID NCT05053347
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether taking flaxseed oil capsules (rich in alpha linolenic acid) for 24 weeks could improve blood sugar levels in 94 adults with elevated blood sugar or mild type 2 diabetes. Participants also had their gut bacteria and fatty acids measured. The goal was to see if this natural supplement could help manage glucose and metabolism.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Flaxseed oil (alpha linolenic acid)
What this could lead to
If it works, this could point toward a simple dietary supplement to help manage blood sugar levels in people with prediabetes or mild diabetes.
What could go wrong
This is a small, completed trial with 94 participants. The effect may be modest, and results may not apply to everyone with diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sinopharm Dongfeng General Hospital
Shiyan, Hubei, 442000, China